-
61
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
Published 2023-04-01Subjects: Get full text
Article -
62
Serum β2-MG, sCHE, and PSGL-1 Expression in Patients with Esophageal Cancer and Their Association with Postoperative Lung Infection After Mediastinoscopy
Published 2025-01-01Subjects: “…p-selectin glycoprotein ligand 1…”
Get full text
Article -
63
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease
Published 2004-01-01Subjects: Get full text
Article -
64
The road ahead: emerging therapies for primary IgA nephropathy
Published 2025-02-01Subjects: “…a proliferation inducing ligand (APRIL)…”
Get full text
Article -
65
NEW PYRIDINE-3-SULFONATO TIN (IV), ANTIMONY (III) AND (V) HALO ADDUCTS AND COMPLEXES: SYNTHESIS AND INFRARED STUDY
Published 2019-03-01Subjects: “…monodentate and tri O-chelating ligand anion…”
Get full text
Article -
66
The algebraic extended atom-type graph-based model for precise ligand–receptor binding affinity prediction
Published 2025-01-01Subjects: Get full text
Article -
67
Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting
Published 2024-12-01Subjects: Get full text
Article -
68
Programmed Cell Death Ligand 1 (PD-L1) and major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in triple-Negative Breast Ca...
Published 2025-02-01Subjects: “…programmed cell death ligand 1…”
Get full text
Article -
69
The transcription factor HMGB2 indirectly regulates APRIL expression and Gd-IgA1 production in patients with IgA nephropathy
Published 2024-12-01Subjects: “…proliferation-inducing ligand…”
Get full text
Article -
70
Dynamic development of microglia and macrophages after spinal cord injury
Published 2025-12-01Subjects: Get full text
Article -
71
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors
Published 2025-04-01Subjects: “…Receptor activator of NF-κB ligand (RANKL)…”
Get full text
Article -
72
Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
Published 2025-01-01Subjects: Get full text
Article -
73
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
Published 2025-12-01Subjects: Get full text
Article